Stifel Nicolaus Lowers Clarivate (NYSE:CLVT) Price Target to $5.00

Clarivate (NYSE:CLVT) had its price objective cut by analysts at Stifel Nicolaus from $6.00 to $5.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 149.38% from the stock’s previous close.

A number of other analysts have also issued reports on CLVT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Barclays cut their price objective on shares of Clarivate from $2.50 to $2.00 and set an “underweight” rating for the company in a research report on Thursday. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, Clarivate currently has an average rating of “Reduce” and a consensus target price of $3.23.

Clarivate Stock Performance

Clarivate stock traded down $0.14 during midday trading on Thursday, reaching $2.00. The stock had a trading volume of 2,208,719 shares, compared to its average volume of 6,797,935. The firm has a market capitalization of $1.28 billion, a PE ratio of -9.55 and a beta of 1.38. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm’s 50-day moving average price is $2.29 and its 200 day moving average price is $2.43. Clarivate has a 12 month low of $1.66 and a 12 month high of $4.55.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.01. The company had revenue of $587.30 million for the quarter, compared to analysts’ expectations of $589.73 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. Clarivate’s revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.18 EPS. As a group, research analysts predict that Clarivate will post 0.65 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clarivate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atairos Partners GP Inc. raised its holdings in shares of Clarivate by 195.3% in the 4th quarter. Atairos Partners GP Inc. now owns 10,232,667 shares of the company’s stock valued at $34,177,000 after acquiring an additional 6,767,667 shares in the last quarter. First Trust Advisors LP purchased a new position in shares of Clarivate during the fourth quarter worth about $16,721,000. Balyasny Asset Management L.P. increased its position in shares of Clarivate by 827.6% in the third quarter. Balyasny Asset Management L.P. now owns 4,882,593 shares of the company’s stock worth $18,700,000 after purchasing an additional 4,356,232 shares during the last quarter. Bank of America Corp DE increased its position in shares of Clarivate by 506.9% in the second quarter. Bank of America Corp DE now owns 2,870,668 shares of the company’s stock worth $12,344,000 after purchasing an additional 2,397,670 shares during the last quarter. Finally, Man Group plc raised its stake in Clarivate by 228.1% in the second quarter. Man Group plc now owns 3,091,139 shares of the company’s stock valued at $13,292,000 after purchasing an additional 2,148,943 shares in the last quarter. 85.72% of the stock is currently owned by hedge funds and other institutional investors.

Clarivate News Roundup

Here are the key news stories impacting Clarivate this week:

• Positive Sentiment: Adjusted earnings exceeded expectations: Clarivate reported $0.19 per share, ahead of the $0.17–$0.18 consensus range and up from $0.18 a year earlier. Clarivate Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: 2026 outlook reaffirmed: Management said it continues to make progress on its Value Creation Plan, with a sharper strategic focus and efforts to improve the company’s financial profile following the planned divestiture of its Life Sciences & Healthcare business. Clarivate Reports Second Quarter 2026 Results
• Neutral Sentiment: Internal CFO succession: Michael Easton, a Clarivate executive with more than 25 years of financial and operational experience, will become CFO on August 8. He replaces Jonathan Collins, who is leaving to pursue another opportunity. The internal appointment may provide continuity, although leadership turnover remains a point investors will monitor. Clarivate Appoints Michael Easton as Chief Financial Officer
• Negative Sentiment: Revenue missed estimates and declined: Quarterly revenue was $587.3 million, below the $589.7 million consensus estimate and down 5.5% year over year. Clarivate also reported a negative net margin, underscoring continued pressure on growth and profitability despite the EPS beat. Clarivate Q2 Earnings Report

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.